Company Profile
Avidity Biosciences Stock Price, News & Analysis
- Ticker:
- RNA
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
12.11 USD (+3.15%)
Close
Last updated: August 6, 2026
210M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, RNA closed up 3.15% at $12.11. No new same-company headline was identified in the current news window.
Company overview
Business overview
Avidity Biosciences is an RNA-targeting company focused on delivering therapies to muscle and other tissues using its antibody oligo conjugate platform. Its story is built around targeted RNA delivery and disease-specific programs.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Avidity sits in advanced biotechnology.
Business Model Characteristics
The company depends on platform validation, clinical data, and the promise of targeted RNA delivery to hard-to-reach tissues.
Position Within the Biotechnology Landscape
Avidity is one of the most interesting RNA-delivery names because platform success could unlock multiple disease areas.
Future catalysts
Avidity Biosciences's catalysts are AOC 1001 and the rest of its muscle-disease programs, where human data keep validating the delivery platform. The market will care about whether the platform keeps producing convincing in-human signals.
Recent news
- 01
- 02
- 03
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
Source: Avidity Biosciences
- 04
- 05
Avidity Biosciences Announces Expected Record Date for Spin-Off
Source: Avidity Biosciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Avidity Biosciences (RNA)?
Avidity Biosciences (RNA) most recently closed at 12.11 USD, a +3.15% move versus the previous session.
What is the market cap of Avidity Biosciences (RNA)?
Avidity Biosciences currently has a market capitalization of 210M USD on BioPharmSignal.
What does Avidity Biosciences do?
Avidity Biosciences is an RNA-targeting company focused on delivering therapies to muscle and other tissues using its antibody oligo conjugate platform. Its story is built around targeted RNA delivery and disease-specific programs.
On which exchange is RNA stock listed?
Avidity Biosciences (RNA) is associated with NASDAQ, United States, Biopharma.
What is Avidity?
Avidity Biosciences's catalysts are AOC 1001 and the rest of its muscle-disease programs, where human data keep validating the delivery platform.
Which conditions is Avidity Biosciences targeting with Avidity?
Avidity Biosciences's catalysts are AOC 1001 and the rest of its muscle-disease programs, where human data keep validating the delivery platform.
How does Avidity Biosciences describe recent progress with Avidity?
Avidity Biosciences's catalysts are AOC 1001 and the rest of its muscle-disease programs, where human data keep validating the delivery platform.
What is Biosciences?
Avidity Biosciences is an RNA-targeting company focused on delivering therapies to muscle and other tissues using its antibody oligo conjugate platform.